GEN Exclusives

More »

GEN News Highlights

More »
Apr 16, 2008

EMD and Merck Serono to Fork Out $50M for New Research Center in Massachusetts

  • Merck Serono and U.S. affiliate, EMD Serono, are shelling out $50 million to expand the Billerica facility outside of Boston, MA. Construction will begin early next year and is expected to be complete in 2010.

    The companies plan on a 210,000 sq. ft. center of excellence in discovery, which will include more than 160,000 sq. ft. of lab space.  The new site will accommodate approximately 250 scientists. About 50 employees will be involved in process development and protein production. The rest will focus on cancer- and fertility-related R&D.

    EMD also has a protein-production plant at Billerica and believes that its proximity to the planned site will help collaborations and the transition from research to manufacturing.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »